Pasqualina Castaldo1, Giovanni M Frascà2, Fabiana Brigante2, Luigi Ferrante3, Simona Magi3, Marianna Pavani3, Edlira Skrami3, Gian Marco Giuseppetti4, Gabriele Polonara4, Salvatore Amoroso3. 1. Department of Biomedical Sciences and Public Health, School of Medicine, University "Politecnica delle Marche", Via Tronto 10/A, 60126, Ancona, Italy. p.castaldo@univpm.it. 2. Nephrology, Dialysis and Renal Transplantation Unit "Ospedali Riuniti of Ancona, Via Conca, 71, 60126, Ancona, Italy. 3. Department of Biomedical Sciences and Public Health, School of Medicine, University "Politecnica delle Marche", Via Tronto 10/A, 60126, Ancona, Italy. 4. Department of Odontostomatologic and Specialized Clinical Sciences, School of Medicine, University "Politecnica delle Marche", Via Tronto 10/A, 60126, Ancona, Italy.
Abstract
OBJECTIVES: To estimate the incidence of contrast-induced acute kidney injury (CI-AKI) after intravenous (iv) iodinated contrast material (ICM) exposure. METHODS: This prospective cohort study included all consecutive patients who underwent radiological investigations using low-osmolar iopamidol 370 mg/ml in a regional hospital over a period of 36 months, without any exclusion criteria. The estimated glomerular filtration rate (eGFR) was evaluated using the MRDR equation before (2-10 days) and after (24-36 h) radiological investigations. CI-AKI was defined as a ≥ 25% decrease in eGFR from baseline. CI-AKI incidence was estimated using a binomial distribution. The association between CI-AKI and demographic and clinical characteristics was modeled using logistic regression. RESULTS: The study included 1541 patients with a median age of 68 (1st-3rd quartiles 58-76) years with various comorbidities, 30% of whom had pre-existing CKD. Patients affected by stage III or IV chronic kidney disease (CKD) received an infusion of 0.9% normal saline (1.0-1.5 ml/kg/h) before and after iso-osmolar iodixanol administration. CI-AKI was observed in 33 patients (2.1%, 95% CI 1.5-3.0). The logistic regression analysis showed that antibiotic and statin therapies were significantly associated with CI-AKI. The probability of developing CI-AKI decreased by 80% in patients taking statins (OR = 0.20, 95% CI 0.03; 0.68) and increased approximately three times in patients with antibiotic therapy compared with those who did not take statins and antibiotics (OR = 2.92, 95% CI 1.21; 6.36). CONCLUSIONS: Our data suggest that low-osmolar iopamidol carries a low incidence of nephrotoxicity, even in subjects with various comorbid conditions or reduced renal function. KEY POINTS: • IV administration of ICM carries a low incidence of nephrotoxicity, which was transient in observed patients. • Statin therapy is negatively associated with AKI in patients exposed to ICM. • Pre-existing impairment of renal function is not associated with AKI in patients exposed to ICM.
OBJECTIVES: To estimate the incidence of contrast-induced acute kidney injury (CI-AKI) after intravenous (iv) iodinated contrast material (ICM) exposure. METHODS: This prospective cohort study included all consecutive patients who underwent radiological investigations using low-osmolar iopamidol 370 mg/ml in a regional hospital over a period of 36 months, without any exclusion criteria. The estimated glomerular filtration rate (eGFR) was evaluated using the MRDR equation before (2-10 days) and after (24-36 h) radiological investigations. CI-AKI was defined as a ≥ 25% decrease in eGFR from baseline. CI-AKI incidence was estimated using a binomial distribution. The association between CI-AKI and demographic and clinical characteristics was modeled using logistic regression. RESULTS: The study included 1541 patients with a median age of 68 (1st-3rd quartiles 58-76) years with various comorbidities, 30% of whom had pre-existing CKD. Patients affected by stage III or IV chronic kidney disease (CKD) received an infusion of 0.9% normal saline (1.0-1.5 ml/kg/h) before and after iso-osmolar iodixanol administration. CI-AKI was observed in 33 patients (2.1%, 95% CI 1.5-3.0). The logistic regression analysis showed that antibiotic and statin therapies were significantly associated with CI-AKI. The probability of developing CI-AKI decreased by 80% in patients taking statins (OR = 0.20, 95% CI 0.03; 0.68) and increased approximately three times in patients with antibiotic therapy compared with those who did not take statins and antibiotics (OR = 2.92, 95% CI 1.21; 6.36). CONCLUSIONS: Our data suggest that low-osmolar iopamidol carries a low incidence of nephrotoxicity, even in subjects with various comorbid conditions or reduced renal function. KEY POINTS: • IV administration of ICM carries a low incidence of nephrotoxicity, which was transient in observed patients. • Statin therapy is negatively associated with AKI in patients exposed to ICM. • Pre-existing impairment of renal function is not associated with AKI in patients exposed to ICM.
Authors: Lorenzo Azzalini; Luz María Vilca; Francesca Lombardo; Enrico Poletti; Alessandra Laricchia; Alessandro Beneduce; Davide Maccagni; Ozan M Demir; Massimo Slavich; Francesco Giannini; Mauro Carlino; Alberto Margonato; Alberto Cappelletti; Antonio Colombo Journal: Int J Cardiol Date: 2018-09-01 Impact factor: 4.164
Authors: Jennifer S McDonald; Robert J McDonald; Rickey E Carter; Richard W Katzberg; David F Kallmes; Eric E Williamson Journal: Radiology Date: 2014-01-16 Impact factor: 11.105
Authors: Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer Journal: Eur Radiol Date: 2011-08-25 Impact factor: 5.315
Authors: Richard J Bruce; Aji Djamali; Kazuhiko Shinki; Steven J Michel; Jason P Fine; Myron A Pozniak Journal: AJR Am J Roentgenol Date: 2009-03 Impact factor: 3.959
Authors: Richard J Solomon; Madhu K Natarajan; Serge Doucet; Samin K Sharma; Cezar S Staniloae; Richard E Katholi; Joseph L Gelormini; Marino Labinaz; Abel E Moreyra Journal: Circulation Date: 2007-06-11 Impact factor: 29.690
Authors: John Eng; Renee F Wilson; Rathan M Subramaniam; Allen Zhang; Catalina Suarez-Cuervo; Sharon Turban; Michael J Choi; Cheryl Sherrod; Susan Hutfless; Emmanuel E Iyoha; Eric B Bass Journal: Ann Intern Med Date: 2016-02-02 Impact factor: 25.391
Authors: Soo Hwan Park; Myung Ho Jeong; In Hyae Park; Jin Soo Choi; Jung Ae Rhee; In Soo Kim; Min Cheol Kim; Jae Yeong Cho; Doo Sun Sim; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang Journal: Int J Cardiol Date: 2016-03-18 Impact factor: 4.164